These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7488471)

  • 1. Is thrombolytic therapy really better than conventional treatment in acute inferior myocardial infarction?
    Lee HS
    Br Heart J; 1995 Oct; 74(4):476; author reply 477-8. PubMed ID: 7488471
    [No Abstract]   [Full Text] [Related]  

  • 2. Is thrombolytic therapy really better than conventional treatment in acute inferior myocardial infarction?
    Ellis CJ; French JK; White HD
    Br Heart J; 1995 Oct; 74(4):476-7; author reply 477-8. PubMed ID: 7488472
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic therapy in acute myocardial infarction.
    Franzosi MG; Garattini S
    J Thromb Haemost; 2005 Dec; 3(12):2807-8. PubMed ID: 16359520
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolytic therapy in acute myocardial infarction.
    Mannucci PM
    J Thromb Haemost; 2005 Dec; 3(12):2806-7. PubMed ID: 16359519
    [No Abstract]   [Full Text] [Related]  

  • 6. The early risk of thrombolytic therapy for acute myocardial infarction: incidence, mechanisms and possible prevention.
    Verheugt FW
    J Cardiovasc Risk; 1998 Apr; 5(2):103-8. PubMed ID: 9821063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary care unit requirements of patients with acute myocardial infarction treated with or without thrombolytic therapy: a pilot study.
    Sadaniantz BT; Sadaniantz A; Garber CE
    Heart Lung; 1994; 23(4):328-32. PubMed ID: 7960859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy for acute ST segment elevation myocardial infarction: should it be given to all patients?
    Conti CR
    Indian Heart J; 2005; 57(1):76-7. PubMed ID: 15852903
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombolytic therapy in acute myocardial infarct in 1992].
    Bergovec M
    Lijec Vjesn; 1993; 115(5-6):170-8. PubMed ID: 8302141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of early stage thrombolytic therapy with venous urokinase for acute myocardial infarction in 24 cases].
    Zhi SQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1452-3. PubMed ID: 16305979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute right ventricular myocardial infarct. New diagnostic and therapeutic approaches in a prognostically unfavorable disease picture].
    Zehender M; Kasper W; Kauder E; Schönthaler M; Geibel A; Olschewski M; Just H
    Med Klin (Munich); 1994 Jul; 89(7):351-9. PubMed ID: 7935223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recording lead V(4)R is associated to enhanced use of fibrinolytic therapy in acute myocardial infarction.
    Harju JA; Eskola MJ; Huhtala H; Niemelä KO; Karhunen PJ; Nikus KC
    J Electrocardiol; 2006 Oct; 39(4):368.e1-5. PubMed ID: 16697401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delays in thrombolytic therapy for acute myocardial infarction: association with mode of transportation to the hospital, age, sex, and race.
    Davis LL; Evans JJ; Strickland JD; Shaw LK; Wagner GS
    Am J Crit Care; 2001 Jan; 10(1):35-42. PubMed ID: 11153182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction.
    Wardrope J; Potts M
    J Accid Emerg Med; 1999 Jan; 16(1):65. PubMed ID: 9918291
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved health benefits of increased use of thrombolytic therapy.
    Fendrick AM; Ridker PM; Bloom BS
    Arch Intern Med; 1994 Jul; 154(14):1605-9. PubMed ID: 8031208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of thrombolytic therapy.
    Mair FS
    Am Fam Physician; 1996 Nov; 54(6):2041-8. PubMed ID: 8900363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction?].
    Halvorsen S; Myhre KI; Steigen T; Nordrehaug JE; Gundersen T; Wiseth R
    Tidsskr Nor Laegeforen; 2003 Jan; 123(2):152-5. PubMed ID: 12607494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.